D.E. Shaw & Co’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.53M | Sell |
24,278
-59,591
| -71% | -$3.77M | ﹤0.01% | 2029 |
|
2025
Q1 | $4.44M | Buy |
83,869
+35,671
| +74% | +$1.89M | ﹤0.01% | 1411 |
|
2024
Q4 | $2.7M | Buy |
48,198
+43,904
| +1,022% | +$2.46M | ﹤0.01% | 1650 |
|
2024
Q3 | $225K | Buy |
+4,294
| New | +$225K | ﹤0.01% | 2783 |
|
2024
Q2 | – | Sell |
-10,462
| Closed | -$453K | – | 3435 |
|
2024
Q1 | $453K | Sell |
10,462
-118,030
| -92% | -$5.11M | ﹤0.01% | 2450 |
|
2023
Q4 | $5.91M | Buy |
+128,492
| New | +$5.91M | 0.01% | 1140 |
|
2023
Q2 | – | Sell |
-278,203
| Closed | -$4.96M | – | 3306 |
|
2023
Q1 | $4.96M | Sell |
278,203
-77,327
| -22% | -$1.38M | 0.01% | 1345 |
|
2022
Q4 | $10.4M | Buy |
355,530
+172,461
| +94% | +$5.02M | 0.01% | 941 |
|
2022
Q3 | $4.49M | Buy |
183,069
+146,577
| +402% | +$3.59M | 0.01% | 1559 |
|
2022
Q2 | $151K | Sell |
36,492
-60,493
| -62% | -$250K | ﹤0.01% | 3471 |
|
2022
Q1 | $1.12M | Buy |
+96,985
| New | +$1.12M | ﹤0.01% | 2803 |
|
2021
Q2 | – | Sell |
-31,653
| Closed | -$673K | – | 3736 |
|
2021
Q1 | $673K | Buy |
+31,653
| New | +$673K | ﹤0.01% | 2381 |
|
2019
Q1 | – | Sell |
-10,982
| Closed | -$295K | – | 2700 |
|
2018
Q4 | $295K | Sell |
10,982
-41,179
| -79% | -$1.11M | ﹤0.01% | 2250 |
|
2018
Q3 | $1.52M | Buy |
52,161
+14,586
| +39% | +$426K | ﹤0.01% | 1659 |
|
2018
Q2 | $1.18M | Buy |
+37,575
| New | +$1.18M | ﹤0.01% | 1837 |
|